Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs

Karson S Putt (Inventor), Jennifer M Pearson (Inventor), Grace Chen (Inventor), Paul J Hergenrother (Inventor), Quinn P Peterson (Inventor), Diana C West (Inventor)

Research output: Patent


Compositions and methods are disclosed in embodiments relating to induction of cell death such as in cancer cells. Compounds and related methods for synthesis and use thereof, including the use of compounds in therapy for the treatment of cancer and selective induction of apoptosis in cells are disclosed. Compounds are disclosed that have lower neurotoxicity effects than other compounds.
Original languageEnglish (US)
U.S. patent number9102661
StatePublished - Aug 11 2015

Cite this